{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:05:07Z","timestamp":1791230707068,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1451,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry & Biology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.chembiol.2009.08.013","type":"journal-article","created":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T12:43:37Z","timestamp":1253882617000},"page":"943-950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["A Peptidomimetic Approach to Targeting Pre-amyloidogenic States in Type II Diabetes"],"prefix":"10.1016","volume":"16","author":[{"given":"James A.","family":"Hebda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishu","family":"Saraogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazin","family":"Magzoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Miranker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2009.08.013_bib1","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1021\/ja072157y","article-title":"A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor","volume":"129","author":"Abedini","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2009.08.013_bib2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1042\/bj20030422","article-title":"Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid","volume":"374","author":"Aitken","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.chembiol.2009.08.013_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-5793(95)01460-8","article-title":"Processing of pro-islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2","volume":"378","author":"Badman","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.chembiol.2009.08.013_bib4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.1141448","article-title":"Adapting proteostasis for disease intervention","volume":"319","author":"Balch","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2009.08.013_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/138955708784223512","article-title":"Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease","volume":"8","author":"Bastianetto","year":"2008","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.chembiol.2009.08.013_bib6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jmb.2003.11.046","article-title":"Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation","volume":"335","author":"Bokvist","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.chembiol.2009.08.013_bib7","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1021\/ja710484d","article-title":"Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide","volume":"130","author":"Brender","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2009.08.013_bib8","doi-asserted-by":"crossref","first-page":"15313","DOI":"10.1074\/jbc.M213128200","article-title":"A broken alpha-helix in folded alpha-Synuclein","volume":"278","author":"Chandra","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2009.08.013_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prot.21887","article-title":"Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid-beta peptide","volume":"72","author":"Chi","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/j.chembiol.2009.08.013_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00125-003-1304-4","article-title":"Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?","volume":"47","author":"Clark","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.chembiol.2009.08.013_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/edrv-15-2-163","article-title":"Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease","volume":"15","author":"Cooper","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.chembiol.2009.08.013_bib12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","article-title":"Conformational properties of alpha-synuclein in its free and lipid-associated states","volume":"307","author":"Eliezer","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.chembiol.2009.08.013_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/13506120108993819","article-title":"Characterization of cholyl-leu-val-phe-phe-ala-OH as an inhibitor of amyloid beta-peptide polymerization","volume":"8","author":"Findeis","year":"2001","journal-title":"Amyloid"},{"key":"10.1016\/j.chembiol.2009.08.013_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000100355","article-title":"Amyloid-beta aggregation","volume":"4","author":"Finder","year":"2007","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.chembiol.2009.08.013_bib15","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1110\/ps.073164107","article-title":"Protein aggregation processes: In search of the mechanism","volume":"16","author":"Frieden","year":"2007","journal-title":"Protein Sci."},{"key":"10.1016\/j.chembiol.2009.08.013_bib16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1073\/pnas.241629998","article-title":"A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants","volume":"99","author":"Friedler","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2009.08.013_bib17","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss","volume":"100","author":"Gong","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2009.08.013_bib18","doi-asserted-by":"crossref","first-page":"10256","DOI":"10.1021\/bi9611164","article-title":"The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR","volume":"35","author":"Grzesiek","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2009.08.013_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1210\/er.2007-0037","article-title":"Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis","volume":"29","author":"Haataja","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.chembiol.2009.08.013_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.biochem.66.1.385","article-title":"Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins","volume":"66","author":"Harper","year":"1997","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.chembiol.2009.08.013_bib21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1042\/BST0320865","article-title":"Amylin receptors: molecular composition and pharmacology","volume":"32","author":"Hay","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.chembiol.2009.08.013_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev.biophys.050708.133622","article-title":"The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: insights form type II diabetes","volume":"38","author":"Hebda","year":"2009","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.chembiol.2009.08.013_bib23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/diabetes.49.3.424","article-title":"Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion","volume":"49","author":"Hohmeier","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.chembiol.2009.08.013_bib24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","article-title":"Islet amyloid and type 2 diabetes mellitus","volume":"343","author":"Hoppener","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chembiol.2009.08.013_bib25","doi-asserted-by":"crossref","first-page":"198304","DOI":"10.1103\/PhysRevLett.92.198304","article-title":"Molecular mechanism of Peptide-induced pores in membranes","volume":"92","author":"Huang","year":"2004","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.chembiol.2009.08.013_bib26","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","article-title":"Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes","volume":"89","author":"Hull","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.chembiol.2009.08.013_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/diabetes.48.2.241","article-title":"Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes","volume":"48","author":"Kahn","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.chembiol.2009.08.013_bib28","doi-asserted-by":"crossref","first-page":"46363","DOI":"10.1074\/jbc.C400260200","article-title":"Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases","volume":"279","author":"Kayed","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2009.08.013_bib29","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jmb.2004.06.086","article-title":"Phospholipid catalysis of diabetic amyloid assembly","volume":"341","author":"Knight","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.chembiol.2009.08.013_bib30","doi-asserted-by":"crossref","first-page":"9496","DOI":"10.1021\/bi060579z","article-title":"Conserved and cooperative assembly of membrane-bound \u03b1-helical states of islet amyloid polypeptide","volume":"45","author":"Knight","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2009.08.013_bib31","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1110\/ps.036350.108","article-title":"Interaction of membrane-bound islet amyloid polypeptide with soluble and crystalline insulin","volume":"17","author":"Knight","year":"2008","journal-title":"Protein Sci."},{"key":"10.1016\/j.chembiol.2009.08.013_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/protein\/gzm076","article-title":"Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide","volume":"21","author":"Koo","year":"2008","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.chembiol.2009.08.013_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jmb.2003.10.045","article-title":"The mechanism of insulin action on islet amyloid polypeptide fiber formation","volume":"335","author":"Larson","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.chembiol.2009.08.013_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S0033583506004422","article-title":"Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?","volume":"39","author":"Lashuel","year":"2006","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.chembiol.2009.08.013_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/13506120701461020","article-title":"Small molecule inhibitors of Abeta assembly","volume":"14","author":"LeVine","year":"2007","journal-title":"Amyloid"},{"key":"10.1016\/j.chembiol.2009.08.013_bib36","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1021\/bi701427q","article-title":"Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR","volume":"46","author":"Luca","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2009.08.013_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0531-5565(03)00004-4","article-title":"Islet amyloid polypeptide and type 2 diabetes","volume":"38","author":"Marzban","year":"2003","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.chembiol.2009.08.013_bib38","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2337\/db05-1672","article-title":"Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes","volume":"55","author":"Matveyenko","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.chembiol.2009.08.013_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/ilar.47.3.225","article-title":"Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes","volume":"47","author":"Matveyenko","year":"2006","journal-title":"ILAR J."},{"key":"10.1016\/j.chembiol.2009.08.013_bib40","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","article-title":"Chemical and biological approaches synergize to ameliorate protein-folding diseases","volume":"134","author":"Mu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2009.08.013_bib41","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1021\/bi0160462","article-title":"Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis","volume":"41","author":"Padrick","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2009.08.013_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00592-004-0149-8","article-title":"Type 2 diabetes mellitus is becoming the most common type of diabetes in school children","volume":"41","author":"Pontiroli","year":"2004","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.chembiol.2009.08.013_bib43","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1021\/bi048582a","article-title":"Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions","volume":"43","author":"Porat","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2009.08.013_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","article-title":"Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism","volume":"67","author":"Porat","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.chembiol.2009.08.013_bib45","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.2337\/diabetes.50.2007.S160","article-title":"beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms","volume":"50 Suppl 1","author":"Porte","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.chembiol.2009.08.013_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1529\/biophysj.107.117168","article-title":"Mechanisms of protein fibril formation: nucleated polymerization with competing off-pathway aggregation","volume":"94","author":"Powers","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.chembiol.2009.08.013_bib47","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1021\/bi8002378","article-title":"Characterization of alpha-synuclein interactions with selected aggregation-inhibiting small molecules","volume":"47","author":"Rao","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2009.08.013_bib48","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1128\/MCB.24.16.7206-7213.2004","article-title":"Scrambled prion domains form prions and amyloid","volume":"24","author":"Ross","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.chembiol.2009.08.013_bib49","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.1073\/pnas.0703306104","article-title":"Fiber-dependent amyloid formation as catalysis of an existing reaction pathway","volume":"104","author":"Ruschak","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2009.08.013_bib50","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1042\/BST0361414","article-title":"alpha-Helix mimetics as inhibitors of protein-protein interactions","volume":"36","author":"Saraogi","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.chembiol.2009.08.013_bib51","article-title":"Synthetic alpha-helix mimetics as agonists and antagonists of IAPP amyloid formation","author":"Saraogi","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.chembiol.2009.08.013_bib52","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1021\/ja810025g","article-title":"Design, synthesis, and evaluation of an alpha-helix mimetic library targeting protein-protein interactions","volume":"131","author":"Shaginian","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2009.08.013_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033583506004173","article-title":"Molecular structure of amyloid fibrils: insights from solid-state NMR","volume":"39","author":"Tycko","year":"2006","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.chembiol.2009.08.013_bib54","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1073\/pnas.0801934105","article-title":"Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2009.08.013_bib55","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1110\/ps.062486907","article-title":"Direct detection of transient \u03b1-helical states in islet amyloid polypeptide","volume":"16","author":"Williamson","year":"2007","journal-title":"Protein Sci."},{"key":"10.1016\/j.chembiol.2009.08.013_bib56","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0507471103","article-title":"Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis","volume":"103","author":"Yan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Chemistry & Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552109002841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552109002841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:13:15Z","timestamp":1761030795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074552109002841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1074552109002841"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2009.08.013","relation":{},"ISSN":["1074-5521"],"issn-type":[{"value":"1074-5521","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Peptidomimetic Approach to Targeting Pre-amyloidogenic States in Type II Diabetes","name":"articletitle","label":"Article Title"},{"value":"Chemistry & Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2009.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}